Regulatory Approvals and Primary Markets

Global Expansion Through Compliance Excellence

Taj Pharma Limited (Taj Pharma) stands as one of India’s leading and most respected pharmaceutical manufacturers with a global reputation for quality, reliability, and innovation. Our regulatory achievements reflect a continuous commitment to meeting the highest international standards in pharmaceutical manufacturing and distribution.

Through years of sustained efforts, Taj Pharma has built a strong global footprint with product registrations and approvals across Asia, Africa, the Middle East, and emerging international markets. Each certification represents not just compliance, but trust—trust earned from stringent national and regional regulatory bodies that oversee safety, efficacy, and quality in pharmaceuticals.

This detailed overview highlights Taj Pharma’s regulatory approvals and primary global markets, categorized by country, authority, and certification type, signifying our dedication to patient safety and global regulatory excellence.


1. Africa: Regional and National Regulatory Approvals

Africa represents one of Taj Pharma’s strongest markets, with approvals spanning both regional regulatory blocs (like EAC and Zazibona) and national agencies (such as NAFDAC Nigeria and ZAMRA Zambia).

East African Community (EAC) Regulatory Approvals

The East African Community (EAC) harmonized regulatory framework allows simultaneous product approvals across multiple member states. Taj Pharma has secured EAC certifications in several countries:

CountryRegulatory Authority / CertificateType / Status
BurundiBurundi Certificate (EAC)EAC Regional Certificate
DR CongoDemocratic Republic Of Congo Certificate (EAC)EAC Regional Certificate
RwandaRwanda Certificate (EAC)EAC Regional Certificate
SomaliaFederal Republic Of Somalia (EAC)EAC Regional Certificate
South SudanSouth Sudan Certificate (EAC)EAC Regional Certificate
TanzaniaTanzania Certificate (EAC)EAC Regional Certificate
UgandaUganda Certificate (EAC)EAC Regional Certificate

Through these EAC recognitions, Taj Pharma demonstrates its adherence to stringent, harmonized quality control systems applicable across the East African region.


Zazibona Collaboration Certificates

The Zazibona Initiative is a collaboration among the Southern African Development Community (SADC) countries aimed at faster, harmonized drug registration. Taj Pharma’s presence under Zazibona signifies approval from a consortium that evaluates quality, safety, and efficacy at a regional level.

CountryRegulatory Authority / CertificateType / Status
BotswanaBotswana Certificate (Zazibona)Zazibona Regional Certificate
MalawiMalawi Certificate (Zazibona)Zazibona Regional Certificate
MozambiqueMozambique Certificate (Zazibona)Zazibona Regional Certificate
NamibiaNamibia Certificate (Zazibona)Zazibona Regional Certificate
South AfricaSouth Africa Certificate (Zazibona)Zazibona Regional Certificate
ZambiaZambia Certificate (Zazibona)Zazibona Regional Certificate

These approvals allow Taj Pharma to distribute across multiple Southern African countries under unified regulatory acceptance, enhancing efficiency and market access.


National Approvals in Africa

Beyond regional frameworks, Taj Pharma has achieved individual country registrations in major African pharmaceutical markets:

CountryRegulatory Authority / CertificateType / Status
NigeriaNigeria Certificate – NAFDACNational Certificate
ZambiaZAMRA Certificate – Zambia MOHNational Certificate
ZimbabweZimbabwe MOH CertificateNational Certificate
YemenYemen MOH CertificateNational Certificate
Ivory CoastIvory Coast CertificateNational Certificate

These national-level approvals solidify Taj Pharma’s position as a trusted supplier of WHO-GMP quality medicines across Africa’s fastest-growing healthcare markets.


2. Middle East and Gulf Region Approvals

The Middle East represents one of the key export zones for Taj Pharma, with consistent progress in obtaining both company registrations and MOH approvals across the Gulf Cooperation Council (GCC) and neighboring countries.

Country / RegionRegulatory Authority / CertificateType / Status
United Arab Emirates (UAE)UAE (GSL) CertificateNational Certificate
OmanOman Company RegistrationCompany Registration
IraqIraq CertificateNational Certificate
IRAQ MOH Certificate (Upcoming)Ministry of Health, IraqUpcoming MOH Certificate
YemenYemen MOH CertificateNational Certificate

These certifications reflect Taj Pharma’s compliance with GCC’s pharmaceutical quality regulations and its capacity to serve the Middle Eastern healthcare sector with reliable and affordable medicines.


3. Asia-Pacific Market Approvals

Asia remains a crucial market for Taj Pharma, offering immense potential for both branded generics and institutional supplies. The company’s regulatory footprint spans Southeast and East Asia.

CountryRegulatory Authority / CertificateType / Status
CambodiaCambodia MOH CertificateNational Regulatory Certificate
PhilippinesPhilippines CertificateNational Certificate
Sri LankaSri Lanka CertificateNational Certificate
South KoreaKorea Certificate (Upcoming)Upcoming Certification

Taj Pharma’s early-stage engagement in Korea and Southeast Asia demonstrates its strategic focus on expanding into highly regulated Asian markets.


4. Latin America and Eurasian Region

Taj Pharma has successfully entered pre-audit stages with several globally recognized regulatory authorities, paving the way for future product registrations in Latin America and Eurasia.

Region / CountryRegulatory Authority / CertificateType / Status
MexicoPre Audit from COFEPRISPre-Audit
Eurasian Economic Union (EAEU)Pre Audit from EAEUPre-Audit
EthiopiaPre Audit from EthiopiaPre-Audit

These audits reflect the company’s proactive efforts toward compliance with COFEPRIS (Mexico), EAEU, and African Union (AU) frameworks—ensuring smooth entry into highly regulated pharmaceutical ecosystems.


5. International and WHO Compliance Certifications

Beyond individual country approvals, Taj Pharma holds globally recognized quality certifications that demonstrate its alignment with international manufacturing and laboratory standards.

CertificationScopeType / Status
WHO GMP CertificateWHO Member CountriesGMP Certification
GLP CertificateInternationalLaboratory Practice Certification
PICS Certificate58 Countries (PIC/S Members)GMP Compliance Certification

These certifications confirm Taj Pharma’s capability to produce medicines that meet World Health Organization (WHO) and PIC/S standards for safety, efficacy, and quality—enabling smooth entry into diverse regulatory territories.


6. Taj Pharma’s Regulatory Strategy: Global Trust Through Documentation Excellence

Taj Pharma’s Regulatory Affairs Department functions as the cornerstone of its international business strategy. The team manages product dossiers, bioequivalence studies, and regulatory submissions with utmost precision.

Each submission is tailored to the specific documentation requirements of the target regulatory authority, ensuring alignment with local technical guidelines such as:

  • CTD/eCTD Dossier Formats
  • Stability Data as per ICH Guidelines
  • Analytical Validation Reports
  • GMP & GLP Compliance Certificates
  • Product Master Files and Clinical Summaries

The company’s regulatory operations are fully integrated with Taj Pharma’s WHO-GMP Certified Plant at Sarigam, Gujarat, India, supporting exports to 50+ countries.


7. Commitment to Quality and Compliance

Taj Pharma’s commitment to regulatory excellence is reinforced through:

  • Periodic WHO-GMP & PIC/S audits
  • Implementation of Quality Management Systems (QMS)
  • Regular training for regulatory and QA teams
  • Investment in compliance-driven technology and documentation systems

Such efforts ensure that every Taj Pharma product meets the stringent expectations of global health authorities, from initial submission to post-market surveillance.


Taj Pharma’s extensive portfolio of regulatory approvals and global certifications underscores its unwavering dedication to quality, transparency, and patient safety. By achieving and maintaining compliance across diverse markets—Africa, Middle East, Asia, and beyond—the company not only enhances its global reach but also strengthens its reputation as a trusted partner in global healthcare supply.

With a vision to expand further into regulated regions such as Europe, LATAM, and CIS, Taj Pharmaceuticals continues to lead the way in global pharmaceutical compliance—building bridges of trust, quality, and healthcare excellence.


Contact Taj Pharma Limited

📍 Manufacturing Address:
Taj Pharma India Ltd.
Plot No. 1019, Vill. Sarigam, G.I.D.C.,
Road No. 10, Dist. Valsad,
Gujarat, India 396155
Certifications: WHO-GMP, ISO 9001:2018, PIC/S, GLP compliant

📞 Call: +91 84484 44095
📱 Call/WhatsApp: +91 7400009975 / +91 7400009976
📧 Email: info@tajpharma.com
🌐 Website: www.tajpharmaindia.com